Copyright
©The Author(s) 2020.
World J Gastrointest Oncol. Aug 15, 2020; 12(8): 877-892
Published online Aug 15, 2020. doi: 10.4251/wjgo.v12.i8.877
Published online Aug 15, 2020. doi: 10.4251/wjgo.v12.i8.877
Figure 6 Changes in colony formation in the SW620 and HCT116 cell lines treated with interleukin-1RA and/or fluorouracil.
A: Colony formation assay showed that interleukin (IL)-1RA single drug treatment decreased the colony formation of SW620 cells, while this parameter significantly decreased in the SW620 cells treated with 6.25 mg/mL fluorouracil (5-FU) combined with 200 mg/mLIL-1RA compared with the untreated cells (5-FU vs Ctrl, P = 0.0027; IL-1RA vs Ctrl, aP = 0.0226; 5-FU and IL-1RA vs IL-1RA, bP = 0.0178; comparison of multiple groups: P = 0.0016); B: Colony formation assay showed that IL-1RA single drug treatment decreased the colony formation of HCT116 cells, while this parameter significantly decreased in the HCT116 cells treated with 6.25 mg/mL 5-FU combined with 200 mg/mLIL-1RA compared with the untreated cells (5-FU vs Ctrl, P = 0.0104; IL-1RA vs Ctrl, aP = 0.0451; 5-FU and IL-1RA vs IL-1RA, bP = 0.0063; comparison of multiple groups: P = 0.0013).
- Citation: Yan Y, Lin HW, Zhuang ZN, Li M, Guo S. Interleukin-1 receptor antagonist enhances chemosensitivity to fluorouracil in treatment of Kras mutant colon cancer. World J Gastrointest Oncol 2020; 12(8): 877-892
- URL: https://www.wjgnet.com/1948-5204/full/v12/i8/877.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i8.877